X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1854) 1854
Newsletter (236) 236
Publication (169) 169
Book Review (25) 25
Reference (10) 10
Magazine Article (7) 7
Book Chapter (5) 5
Book / eBook (4) 4
Newspaper Article (3) 3
Dissertation (2) 2
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1741) 1741
chickenpox (983) 983
child (898) 898
female (867) 867
chickenpox - prevention & control (815) 815
male (796) 796
herpesvirus 3, human - immunology (772) 772
vaccination (770) 770
child, preschool (740) 740
infant (655) 655
index medicus (651) 651
immunology (624) 624
adult (566) 566
chickenpox - immunology (562) 562
adolescent (545) 545
chickenpox vaccine - immunology (535) 535
vaccines (513) 513
infectious diseases (491) 491
immunization (490) 490
children (471) 471
varicella (448) 448
chickenpox vaccine - administration & dosage (447) 447
chickenpox - epidemiology (435) 435
chickenpox vaccine (432) 432
pediatrics (382) 382
antibodies, viral - blood (308) 308
epidemiology (301) 301
middle aged (298) 298
viruses (270) 270
united-states (262) 262
chickenpox vaccine - adverse effects (253) 253
infections (249) 249
vaccine (246) 246
chicken pox (244) 244
virus diseases (242) 242
shingles (238) 238
varicella-zoster virus (233) 233
medicine, research & experimental (230) 230
herpes zoster - prevention & control (226) 226
aged (214) 214
herpes-zoster (214) 214
herpes zoster (210) 210
health aspects (202) 202
healthy-children (197) 197
research (193) 193
herpes zoster - immunology (181) 181
immunity (180) 180
medical research (180) 180
prevention (175) 175
herpes zoster - epidemiology (173) 173
infection (172) 172
measles (172) 172
varicella vaccine (168) 168
medicine, experimental (163) 163
microbiology (162) 162
infant, newborn (161) 161
incidence (157) 157
young adult (155) 155
antibodies (154) 154
viral vaccines - immunology (149) 149
immunization schedule (147) 147
mumps (147) 147
vaccines, attenuated - immunology (146) 146
allergy and immunology (140) 140
risk factors (140) 140
safety (138) 138
age (134) 134
adults (130) 130
animals (130) 130
antibodies, viral - analysis (127) 127
rubella (127) 127
chickenpox - virology (126) 126
seroepidemiologic studies (126) 126
enzyme-linked immunosorbent assay (125) 125
herpesvirus 3, human - genetics (121) 121
pregnancy (121) 121
chickenpox vaccine - therapeutic use (116) 116
virus (114) 114
zoster-virus (110) 110
age factors (105) 105
analysis (105) 105
virology (105) 105
medicine, general & internal (103) 103
viral vaccines (102) 102
chickenpox - complications (101) 101
immunogenicity (99) 99
time factors (98) 98
herpesvirus 3, human - isolation & purification (96) 96
population (96) 96
chickenpox - transmission (95) 95
complications (95) 95
antibodies, viral - biosynthesis (94) 94
viral vaccines - administration & dosage (94) 94
immunocompromised host (93) 93
children & youth (91) 91
immunity, cellular (91) 91
public health (91) 91
aged, 80 and over (89) 89
varicella zoster virus (89) 89
zoster virus (89) 89
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1996) 1996
French (20) 20
Japanese (19) 19
Spanish (19) 19
German (18) 18
Italian (7) 7
Russian (7) 7
Chinese (6) 6
Polish (6) 6
Danish (3) 3
Hebrew (3) 3
Hungarian (3) 3
Portuguese (3) 3
Dutch (2) 2
Finnish (2) 2
Czech (1) 1
Icelandic (1) 1
Norwegian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 20, pp. 2379 - 2386
Highlights • ProQuad® and hexavalent vaccine immunogenicity is similar if given together or alone. • ProQuad® and hexavalent vaccine have consistent safety... 
Allergy and Immunology | ProQuad® immunization | Rubella | Measles | ClinicalTrials.gov NCT: 00432042 | Varicella | Mumps | Hexavalent vaccine | ProQuad ® immunization | MEDICINE, RESEARCH & EXPERIMENTAL | PEDIATRIC COMBINATION VACCINES | IMMUNIZATION PRACTICES ACIP | MMRV VACCINATION | PREVENTION | RISK | FEBRILE SEIZURES | IMMUNOLOGY | ProQuad (R) immunization | CHILDREN | ADVISORY-COMMITTEE | IMPACT | RECOMMENDATIONS | Immunization, Secondary - adverse effects | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccination | Infant | Male | Haemophilus Vaccines - administration & dosage | Haemophilus influenzae type b - immunology | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Female | Immunization Schedule | Antibodies, Bacterial - blood | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Chickenpox Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Measles-Mumps-Rubella Vaccine - administration & dosage | Chickenpox Vaccine - administration & dosage | Haemophilus Vaccines - immunology | Measles-Mumps-Rubella Vaccine - adverse effects | Measles-Mumps-Rubella Vaccine - immunology | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - adverse effects | Antibodies, Bacterial - immunology | Antibodies, Viral - immunology | Hepatitis B Vaccines - immunology | Chickenpox Vaccine - immunology | Infants | Safety and security measures | Vaccines | Schedules | Immunization | Chicken pox | Infections | Diphtheria | Whooping cough | Hepatitis | Poliomyelitis | Influenza | Response rates | Tetanus
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 36, pp. 4278 - 4284
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 12, pp. 1440 - 1445
Highlights • Post-transplant vaccinations were reviewed in pediatric liver recipients. • 4 live-attenuated and 3 inactivated vaccines were given after... 
Allergy and Immunology | Live-attenuated vaccine | Immunization | Children | Inactivated vaccine | Liver transplantation | MEDICINE, RESEARCH & EXPERIMENTAL | HUMORAL IMMUNOGENICITY | BILIARY ATRESIA CHILDREN | MEASLES | VIRUS VACCINE | IMMUNOLOGY | ZOSTER | VARICELLA INFECTION | Liver Transplantation | Age Factors | Humans | Child, Preschool | Infant | Mumps - prevention & control | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Whooping Cough - prevention & control | Vaccines, Attenuated - administration & dosage | Female | Immunization Schedule | Safety | Child | Measles-Mumps-Rubella Vaccine - administration & dosage | Chickenpox - prevention & control | Chickenpox Vaccine - administration & dosage | Measles-Mumps-Rubella Vaccine - adverse effects | Measles-Mumps-Rubella Vaccine - immunology | Vaccines, Inactivated - adverse effects | Vaccines, Attenuated - immunology | Vaccines, Inactivated - immunology | Vaccines, Combined - adverse effects | Encephalitis, Japanese - prevention & control | Vaccines, Inactivated - administration & dosage | Adolescent | Hepatitis B - prevention & control | Immunocompromised Host | Vaccines, Attenuated - adverse effects | Chickenpox Vaccine - immunology | Pediatrics | Safety and security measures | Vaccination | Liver | Organ transplant recipients | Transplantation | Vaccines | Encephalitis | Mumps | Transplants & implants | Laboratories
Journal Article
Vaccine, ISSN 0264-410X, 10/2017, Volume 35, Issue 45, pp. 6166 - 6171
Journal Article
Journal Article
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 08/2013, Volume 32, Issue 8, pp. 889 - 897
OBJECTIVE:To assess antibody persistence and booster immunogenicity and safety of a new, fully liquid, hexavalent DTaP-IPV-Hep B-PRP-T vaccine. METHODS:Phase... 
Expanded Program on Immunization schedule | hexavalent | booster | antibody persistence | pediatric | vaccination | INFECTIOUS DISEASES | CONJUGATE COMBINED VACCINE | HEPATITIS-B-VACCINE | DIPHTHERIA | PARTICLES | TO-T VACCINE | SAFETY | IMMUNOLOGY | ACELLULAR PERTUSSIS | PENTAXIM(TM) | IMMUNOGENICITY | INACTIVATED POLIOVIRUS | PEDIATRICS | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Infant | Haemophilus Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Immunization, Secondary | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Immunization Schedule | Antibodies, Bacterial - blood | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Chickenpox Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Measles-Mumps-Rubella Vaccine - administration & dosage | Chickenpox Vaccine - administration & dosage | Tetanus Toxoid - adverse effects | Haemophilus Vaccines - immunology | Measles-Mumps-Rubella Vaccine - adverse effects | Tetanus Toxoid - administration & dosage | Measles-Mumps-Rubella Vaccine - immunology | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - adverse effects | South Africa | Hepatitis B Vaccines - immunology | Chickenpox Vaccine - immunology | Tetanus Toxoid - immunology
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2012, Volume 206, Issue 8, pp. 1280 - 1290
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 30, Issue 3, pp. 668 - 674
Journal Article